Adial Pharmaceuticals宣布360万美元的公开募股定价

2025-06-17 20:52

Adial Pharmaceuticals (NASDAQ:ADIL) on Tuesday announced the pricing of its public offering for the purchase and sale of 11.1M shares of common stock of the company, together with Series D warrants to purchase up to 11.1M shares of common stock and Series E warrants to purchase up to 8.33M shares of common stock at a combined offering price of $0.3251 per share and accompanying warrants, for aggregate gross proceeds of about $3.6M.
The Series D warrants and the Series E warrants will have an exercise price of $0.35 per share.
The closing of the offering is expected to occur on or about June 18, 2025.
In connection with the offering, the company also agreed to amend certain existing Series B-1 warrants to purchase up to 2.48M shares of common stock and certain existing Series C-1 warrants to purchase up to 4.03M shares of common stock with an exercise price of $0.74 per share.
ADIL -30.29% premarket to $0.2266.
Source: Press Release

More on Adial Pharmaceuticals